OFM
Omega Fund Management Portfolio holdings
AUM
$287M
1-Year Est. Return
97.11%
This Fund
S&P 500
1 Year Est. Return
+97.11%
AUM
$287M
AUM Growth
+$64.2M
(+29%)
Holding
12
Top Sells
| 1 | +$16.1M | |
| 2 | +$7.01M | |
| 3 | +$4.65M | |
| 4 |
UPB
Upstream Bio Inc
UPB
|
+$747K |
| 5 |
enGene Therapeutics Warrants
ENGNW
|
+$63.4K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Nuvation Bio
NUVB
$1.72B
| $72.4M | 25.27% |
8,081,089
-750,000
|
|
||
|
BBOT
2
BridgeBio Oncology
BBOT
$735M
| $41.2M | 14.37% |
3,289,661
|
|
||
|
BBNX
3
Beta Bionics
BBNX
$495M
| $40.1M | 14% |
1,316,183
-603,942
|
|
||
|
BCAX
4
Bicara Therapeutics
BCAX
$1.5B
| $37.1M | 12.95% |
2,204,650
|
|
||
|
KMTS
5
Kestra Medical Technologies
KMTS
$1.32B
| $36.4M | 12.71% |
1,373,591
-272,302
|
|
||
|
UPB
6
Upstream Bio Inc
UPB
$516M
| $36M | 12.57% |
1,326,293
-30,000
|
|
||
|
7
enGene Therapeutics
ENGN
$539M
| $7.91M | 2.76% |
876,357
+350,000
|
|
||
|
ALMS
8
Alumis Inc
ALMS
$3.14B
| $6.38M | 2.23% |
653,223
|
|
||
9
Sana Biotechnology
SANA
$907M
| $3.43M | 1.2% |
843,750
|
|
||
|
IMA
10
ImageneBio Inc
IMA
$63.8M
| $3.14M | 1.1% |
455,361
|
|
||
11
Replimune Group
REPL
$217M
| $2.42M | 0.84% |
248,672
|
|
||
|
12
enGene Therapeutics Warrants
ENGNW
$25M
| – | – |
-89,702
|
|